Categories
Archives
- 2026
- 2025
- 2024
- 2023
Mar
27
UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Mar
12
Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and Effectiveness of FINTEPLA® (fenfluramine) in Children and Adults with Dravet Syndrome
Mar
07
Improving Dermatology Outcomes with Timely Diagnosis and Long-Lasting Treatment Options
Mar
07
BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden
Mar
07
BIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-Term Efficacy in Moderate-to-Severe Plaque Psoriasis
Mar
05
Voices on Value: Prioritizing Patients Now and Into the Future
Mar
04
CareCompass: Transforming the care journey of caregivers and their loved ones with Dravet Syndrome or Lennox-Gastaut Syndrome
Feb
27
On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth
Feb
25
Shining a Light on Resilience: Honoring Black History Month and Raising Awareness for Epilepsy
